Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells-Reference-Cited by-同舟云学术

Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells

Published:2013-02 Issue:3 Volume:85 Page:325-334
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Wu Chung-Pu,Sim Hong-May,Huang Yang-Hui,Liu Yen-Chen,Hsiao Sung-Han,Cheng Hsing-Wen,Li Yan-Qing,Ambudkar Suresh V.,Hsu Sheng-Chieh

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference50 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

3. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance;McCubrey;Adv Enzyme Regul,2006

4. Mechanism of activation of the RAF–ERK signaling pathway by oncogenic mutations of B-RAF;Wan;Cell,2004

5. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Connecting the dots: LncRNAs in the KRAS pathway and cancer;Pathology - Research and Practice;2024-10

2. Nrf2-Mediated Antioxidant Response and Drug Efflux Transporters Upregulation as Possible Mechanisms of Resistance in Photodynamic Therapy of Cancers;OncoTargets and Therapy;2024-08

3. An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared to Auristatin-F-Based Antibody-Drug Conjugates;Molecular Pharmaceutics;2024-07-24

4. Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells;Cancer Chemotherapy and Pharmacology;2024-01-16

5. Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance;NAR Cancer;2024-01-09